Access cutting-edge long covid treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access long covid specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related long covid treatment provided free
The primary objective of this study is to evaluate the safety and efficacy of Larazotide (AT1001) versus placebo in children and adults 7 to ≤50 years of age who present with symptoms of Long COVID in the presence of SARS-CoV-2 antigenemia. AT1001 (n=100) or placebo (n=50) will be administered orally four times a day (QID) for 21 days.
Sponsor: Massachusetts General Hospital
Check if you qualify for this long covid clinical trial in Boston, MA
If you're searching for long covid treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced long covid specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.